Enhanced antitumor effect of doxorubicin through active-targeted nanoparticles in doxorubicin-resistant triple-negative breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhanced antitumor effect of doxorubicin through active-targeted nanoparticles in doxorubicin-resistant triple-negative breast cancer

Published:2022-11 Issue: Volume:77 Page:103845
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Hsiao Chi-Huang,Huang Hau-Lun,Chen Yi-Hsuan,Chen Mei-Lin,Lin Yu-Hsin^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference52 articles.

1. Tamoxifen-loaded functionalized graphene nanoribbons for breast cancer therapy;Abu Lila;J. Drug Deliv. Sci. Technol.,2021

2. Breast cancer treatment: a review;Waks;JAMA,2019

3. Nanotechnology-based siRNA delivery strategies for treatment of triple negative breast cancer;Chadar;Int. J. Pharm.,2021

4. Breast cancer;Harbeck;Lancet,2017

5. Triple-negative breast cancer;Chacón;Breast Cancer Res.,2010

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymeric nanomaterials-based theranostic platforms for triple-negative breast cancer (TNBC) treatment;International Journal of Pharmaceutics;2024-07

2. Cross-linked lipoic acid nanoparticles with indole-3-methanol loading for the PTEN-mediated TNBC treatment;Journal of Materials Science & Technology;2024-05

3. Recent Trends in Curcumin-Containing Inorganic-Based Nanoparticles Intended for In Vivo Cancer Therapy;Pharmaceutics;2024-01-26

4. Charcoal Nanoparticles as a Delivery System for Doxorubicin and Sorafenib in Treatment of Hepatocellular Carcinoma;Advances in Nanoparticles;2024

5. Pharmacokinetics and tumor delivery of nanoparticles;Journal of Drug Delivery Science and Technology;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3